Opana - 63481-813-60 - (oxymorphone hydrochloride)

Alphabetical Index


Drug Information of Opana

Product NDC: 63481-813
Proprietary Name: Opana
Non Proprietary Name: oxymorphone hydrochloride
Active Ingredient(s): 7.5    mg/1 & nbsp;   oxymorphone hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Opana

Product NDC: 63481-813
Labeler Name: Endo Pharmaceuticals Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA201655
Marketing Category: NDA
Start Marketing Date: 20120320

Package Information of Opana

Package NDC: 63481-813-60
Package Description: 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (63481-813-60)

NDC Information of Opana

NDC Code 63481-813-60
Proprietary Name Opana
Package Description 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (63481-813-60)
Product NDC 63481-813
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name oxymorphone hydrochloride
Dosage Form Name TABLET, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20120320
Marketing Category Name NDA
Labeler Name Endo Pharmaceuticals Inc.
Substance Name OXYMORPHONE HYDROCHLORIDE
Strength Number 7.5
Strength Unit mg/1
Pharmaceutical Classes Full Opioid Agonists [MoA],Opioid Agonist [EPC]

Complete Information of Opana


General Information